Author: Rayman, G; Lumb, A; Kennon, B; Cottrell, C; Nagi, D; Page, E; Voigt, D; Courtney, H; Atkins, H; Platts, J; Higgins, K; Dhatariya, K; Patel, M; Narendran, P; Kar, P; Newlandâ€Jones, P; Stewart, R; Burr, O; Thomas, S
Title: Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVIDâ€19 pandemic Cord-id: bfe62ukg Document date: 2020_5_18
ID: bfe62ukg
Snippet: During the early stages of the COVIDâ€19 pandemic, hospitals in London, the UK epicentre, reported an unusually high number of people presenting with COVIDâ€19 disease developing diabetic ketoacidosis, hyperosmolar hyperglycaemic state, or a combination of both. Very high doses of insulin were often needed to manage the hyperglycaemia. It has been proposed that these metabolic disturbances may result from severe insulin resistance combined with decreased insulin secretion due to beta cell dysf
Document: During the early stages of the COVIDâ€19 pandemic, hospitals in London, the UK epicentre, reported an unusually high number of people presenting with COVIDâ€19 disease developing diabetic ketoacidosis, hyperosmolar hyperglycaemic state, or a combination of both. Very high doses of insulin were often needed to manage the hyperglycaemia. It has been proposed that these metabolic disturbances may result from severe insulin resistance combined with decreased insulin secretion due to beta cell dysfunction.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date